Signup Crypto ETF Stocks News

CAR FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 24 Deadline in Securities Class Action - CAR - Avis Budget Gr ( NASDAQ:CAR )

NEW YORK, June 15, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. CAR between February 16, 2024 and February 10, 2025, both dates inclusive ( the "Class Period" ) , of the important June 24, 2025 ...

Source: www.benzinga.com
June 15, 2025 | 15:32:00
Category: News

Last week's top gainer Mid cap stocks - Quantum Computing ( NASDAQ:QUBT ) , Transocean ( NYSE:RIG ) , Oklo ( NYSE:OKLO )

Oklo surged 26.6% after winning a U.S. defense energy award and raising $400M, with analyst upgrades boosting momentum. Most mid-cap gainers, including Transocean and Civitas, rose on soaring oil prices driven by Middle East conflict.

Source: www.benzinga.com
June 15, 2025 | 16:07:45
Category: Trading

CGTN: From father to son: The enduring values guiding Xi Jinping

BEIJING, June 15, 2025 ( GLOBE NEWSWIRE ) -- During a 2021 visit to the very place where his father had once worked, Chinese President Xi Jinping softly recited a line now displayed prominently in the exhibition hall - "Sit upright at the side of the people."

Source: www.benzinga.com
June 15, 2025 | 16:29:07
Category: General

2 Top Tech Stocks That Could Help Make You a Millionaire

Investors are underestimating these large companies hiding in plain sight.

Source: www.fool.com
June 15, 2025 | 13:45:00
Category: News

AST SpaceMobile: A High-Risk, High-Reward Play on the Future of Connectivity

Forget what you thought you knew about satellite phones. While market attention remains fixed on artificial intelligence and quantum computing, a Texas-based company is making significant strides in its mission to revolutionize global internet access.AST SpaceMobile ( NASDAQ: ASTS ) is on the ...

Source: www.fool.com
June 15, 2025 | 14:00:00
Category: News

Could This Made-in-the-USA Drone Company Dethrone China's DJI?

At the right price, SiFly could outcompete DJI and recapture the American drone market.

Source: www.fool.com
June 15, 2025 | 14:05:00
Category: News

Could Buying Visa Stock Today Set You Up for Life?

We all want to find that one investment that can make us huge returns. In the past, Visa ( NYSE: V ) has done just that.The world's dominant payments processing entity has produced a total return of 2,880% since its initial public offering ( IPO ) in 2008.

Source: www.fool.com
June 15, 2025 | 14:15:00
Category: News

Same Role, Same Experience-One Tech Worker Found Out Colleague Made Nearly Double The Money. It Could End Up Badly For One Of Them

A tech employee recently discovered a jaw-dropping pay gap between them and a colleague with the same title and similar experience. While they earn $60,000 a year, their coworker, "John," makes $115,000. The two work at a large tech company, and the disparity sparked a flood of advice and opinion ...

Source: www.benzinga.com
June 15, 2025 | 14:31:49
Category: News

WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - WST - West Pharmaceutical Servs ( NYSE:WST )

NEW YORK, June 15, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. WST between February 16, 2023 and February 12, 2025, both dates inclusive ( the "Class Period" ) , of the important ...

Source: www.benzinga.com
June 15, 2025 | 14:33:00
Category: News

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran ( lonvo-z ) in Patients with Hereditary Angioedema ( HAE ) at the European Academy of Allergy and Clinical Immunology Congress - Intellia Therapeutics ( NASDAQ:NTLA )

With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, demonstrating the potential of lonvo-z to become the ...

Source: www.benzinga.com
June 15, 2025 | 14:45:00
Category: General

© Natavest 2025 - 2026